2019
Impact of Switching Youth With Diabetes to Insulin Degludec in Clinical Practice
Elahi S, Patel AD, Guandalini C, Steffen A, Sherr J, Tamborlane WV, Van Name MA. Impact of Switching Youth With Diabetes to Insulin Degludec in Clinical Practice. Endocrine Practice 2019, 25: 226-229. PMID: 30913005, DOI: 10.4158/ep-2018-0417.Peer-Reviewed Original ResearchConceptsType 1 diabetesInsulin degludecDiabetic ketoacidosisGlycemic controlCurrent regimenPatient's current regimenRetrospective chart reviewMonths of treatmentBeta-cell functionType 2 diabetesDiabetes-PatientenUltralong durationChart reviewGlycemic targetsBasal insulinHemoglobin A1cGlycemic outcomesMissed dosesOutcome differencesIDegClinical practiceDiabetes struggleDiabetesType 2Degludec
2016
American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement
Bailey TS, Grunberger G, Bode BW, Handelsman Y, Hirsch IB, Jovanovič L, Roberts V, Rodbard D, Tamborlane WV, Walsh J. American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement. Endocrine Practice 2016, 22: 231-262. PMID: 26848630, DOI: 10.4158/ep151124.cs.Peer-Reviewed Original Research
2015
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, Hofer S, Fritsch M, Schober E, Svensson J, Almdal T, Young R, Warner JT, Delemer B, Souchon PF, Holl RW, Karges W, Kieninger DM, Tigas S, Bargiota A, Sampanis C, Cherubini V, Gesuita R, Strele I, Pildava S, Coppell KJ, Magee G, Cooper JG, Dinneen SF, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Veeze H, Aanstoot HJ, Khalangot M, Tamborlane WV, Miller KM. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic Medicine 2015, 32: 1036-1050. PMID: 25510978, DOI: 10.1111/dme.12676.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAustriaDenmarkDiabetes Mellitus, Type 1EnglandFemaleFranceGermanyGlycated HemoglobinGreeceGuideline AdherenceHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsIrelandItalyLatviaMaleNetherlandsNew ZealandNorthern IrelandNorwayPractice Guidelines as TopicRegistriesScotlandSwedenUkraineUnited StatesWalesWestern AustraliaYoung Adult
2009
Practical Aspects of Real-Time Continuous Glucose Monitors
Ives B, Sikes K, Urban A, Stephenson K, Tamborlane WV. Practical Aspects of Real-Time Continuous Glucose Monitors. The Science Of Diabetes Self-Management And Care 2009, 36: 53-62. PMID: 19933872, PMCID: PMC2863334, DOI: 10.1177/0145721709352010.Peer-Reviewed Original Research
2006
Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment
Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, Weinzimer SA. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. The Journal Of Pediatrics 2006, 149: 227-232. PMID: 16887440, DOI: 10.1016/j.jpeds.2006.03.052.Peer-Reviewed Original ResearchConceptsType 1 diabetes mellitusRace/ethnicityLow socioeconomic statusSocioeconomic statusDiabetes mellitusLarge clinical practiceDuration of diabetesOptimal glycemic controlBody mass indexPoor metabolic controlAge 18 yearsGlycemic targetsInjection therapyGlycemic controlDiabetes controlMass indexFemale sexDatabase reviewInsulin administrationIntensive treatmentMonths durationTrial recommendationsMultiple linear regression analysisTherapeutic goalsClinical practice